Literature DB >> 11090915

Bombesin and the brain-gut axis.

V Martinez1, Y Taché.   

Abstract

Bombesin is the first peptide shown to act in the brain to influence gastric function and the most potent peptide to inhibit acid secretion when injected into the cerebrospinal fluid (CSF) in rats and dogs. Bombesin responsive sites include specific hypothalamic nuclei (paraventricular nucleus, preoptic area and anterior hypothalamus), the dorsal vagal complex as well as spinal sites at T9-T10. The antisecretory effect of central bombesin encompasses a variety of endocrine/paracrine (gastrin, histamine) or neuronal stimulants. Bombesin into the CSF induces an integrated gastric response (increase in bicarbonate, and mucus, inhibition of acid, pepsin, vagally mediated contractions) enhancing the resistance of the mucosa to injury through autonomic pathways. The physiological significance of central action of bombesin on gastric function is still to be unraveled.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090915     DOI: 10.1016/s0196-9781(00)00293-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  11 in total

Review 1.  Brainstem neuropeptides and vagal protection of the gastric mucosal against injury: role of prostaglandins, nitric oxide and calcitonin-gene related peptide in capsaicin afferents.

Authors:  Y Tache
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 2.  Role of brainstem TRH/TRH-R1 receptors in the vagal gastric cholinergic response to various stimuli including sham-feeding.

Authors:  Y Taché; H Yang; M Miampamba; V Martinez; P Q Yuan
Journal:  Auton Neurosci       Date:  2006-03-06       Impact factor: 3.145

3.  Immediate Release of Gastrin-Releasing Peptide Mediates Delayed Radiation-Induced Pulmonary Fibrosis.

Authors:  Robert M Tighe; Karissa Heck; Erik Soderblom; Shutang Zhou; Anastasiya Birukova; Kenneth Young; Douglas Rouse; Jessica Vidas; Miglena K Komforti; Christopher B Toomey; Frank Cuttitta; Mary E Sunday
Journal:  Am J Pathol       Date:  2019-03-18       Impact factor: 4.307

4.  Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils.

Authors:  Rafael Sanguinetti Czepielewski; Bárbara Nery Porto; Lucas Bortolotto Rizzo; Rafael Roesler; Ana Lúcia Abujamra; Larissa Garcia Pinto; Gilberto Schwartsmann; Fernando de Queiroz Cunha; Cristina Bonorino
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

5.  Vagal afferent control of opioidergic effects in rat brainstem circuits.

Authors:  Kirsteen N Browning; Zhongling Zheng; Thomas W Gettys; R Alberto Travagli
Journal:  J Physiol       Date:  2006-07-06       Impact factor: 5.182

6.  A Stress-Related Peptide Bombesin Centrally Induces Frequent Urination through Brain Bombesin Receptor Types 1 and 2 in the Rat.

Authors:  Takahiro Shimizu; Shogo Shimizu; Youichirou Higashi; Kumiko Nakamura; Naoki Yoshimura; Motoaki Saito
Journal:  J Pharmacol Exp Ther       Date:  2016-01-04       Impact factor: 4.030

7.  Somatostatin receptor type 2 mediates bombesin-induced inhibition of gastric acid secretion in mice.

Authors:  Laura Piqueras; Yvette Taché; Vicente Martínez
Journal:  J Physiol       Date:  2003-04-11       Impact factor: 5.182

Review 8.  The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors.

Authors:  A Stengel; M Mori; Y Taché
Journal:  Obes Rev       Date:  2013-08-27       Impact factor: 9.213

Review 9.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

10.  Comparative study of 64Cu/NOTA-[D-Tyr6,βAla11,Thi13,Nle14]BBN(6-14) monomer and dimers for prostate cancer PET imaging.

Authors:  Patrick Fournier; Véronique Dumulon-Perreault; Samia Ait-Mohand; Réjean Langlois; François Bénard; Roger Lecomte; Brigitte Guérin
Journal:  EJNMMI Res       Date:  2012-02-14       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.